Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgos Karakousis

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Surgical Oncology|August 24, 2015
Update for ASCO 2015 sarcoma sessionsGiorgos Karakousis
The Lancet. Oncology|February 3, 2020
Adjuvant therapy for melanoma: how to choose?Giorgos Karakousis
Annals of Surgery|May 27, 2026
Pre-operative Radiation for Resectable Retroperitoneal Sarcoma: Where are we With Risk-benefit Calculus?Giorgos Karakousis
Annals of Surgical Oncology|January 2, 2022
Prognostic Biomarkers in Melanoma: The Legacy of a Surgeon Scientist Who Followed the DataGiorgos Karakousis, Jonathan Zager
Surgical Oncology Clinics of North America|September 20, 2017
An Update on Randomized Clinical Trials in MelanomaGiorgos Karakousis, Charlotte Ariyan
Annals of Surgical Oncology|November 24, 2021
Melanoma Surgery in the Emerging Era of Effective Neoadjuvant TherapyJohn Miura, Giorgos Karakousis
Annals of Surgical Oncology|June 11, 2009
The case for selective use of pre-operative chemotherapy for hepatic colorectal metastases: more is not always betterGiorgos Karakousis, Yuman Fong
Annals of Surgical Oncology|February 7, 2021
Improving Access to Specialized Centers is Not Enough to Mitigate Socioeconomic Disparities in Complex Oncologic SurgeryJohn Miura, Giorgos Karakousis
Annals of Surgical Oncology|January 5, 2024
Educating Cancer-Associated Fibroblasts (CAFs): Are They the Student or the Teacher?Ajay V Maker, Giorgos Karakousis
Annals of Surgical Oncology|February 22, 2023
Commentary re PRADO: De-escalation in Melanoma After Neoadjuvant Therapy: When to Cut and When to Cut BackMark B Faries, Giorgos Karakousis
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Surgical Oncology|August 24, 2015
Update for ASCO 2015 sarcoma sessionsGiorgos Karakousis
The Lancet. Oncology|February 3, 2020
Adjuvant therapy for melanoma: how to choose?Giorgos Karakousis
Annals of Surgery|May 27, 2026
Pre-operative Radiation for Resectable Retroperitoneal Sarcoma: Where are we With Risk-benefit Calculus?Giorgos Karakousis
Annals of Surgical Oncology|January 2, 2022
Prognostic Biomarkers in Melanoma: The Legacy of a Surgeon Scientist Who Followed the DataGiorgos Karakousis, Jonathan Zager
Surgical Oncology Clinics of North America|September 20, 2017
An Update on Randomized Clinical Trials in MelanomaGiorgos Karakousis, Charlotte Ariyan
Annals of Surgical Oncology|November 24, 2021
Melanoma Surgery in the Emerging Era of Effective Neoadjuvant TherapyJohn Miura, Giorgos Karakousis
Annals of Surgical Oncology|June 11, 2009
The case for selective use of pre-operative chemotherapy for hepatic colorectal metastases: more is not always betterGiorgos Karakousis, Yuman Fong
Annals of Surgical Oncology|February 7, 2021
Improving Access to Specialized Centers is Not Enough to Mitigate Socioeconomic Disparities in Complex Oncologic SurgeryJohn Miura, Giorgos Karakousis
Annals of Surgical Oncology|January 5, 2024
Educating Cancer-Associated Fibroblasts (CAFs): Are They the Student or the Teacher?Ajay V Maker, Giorgos Karakousis
Annals of Surgical Oncology|February 22, 2023
Commentary re PRADO: De-escalation in Melanoma After Neoadjuvant Therapy: When to Cut and When to Cut BackMark B Faries, Giorgos Karakousis
Pageof 10